These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26406581)

  • 21. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of bioactive compounds that contribute to the α-glucosidase inhibitory activity of rosemary.
    Ma YY; Zhao DG; Zhang R; He X; Li BQ; Zhang XZ; Wang Z; Zhang K
    Food Funct; 2020 Feb; 11(2):1692-1701. PubMed ID: 32037413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.
    Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI
    Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies.
    Imran S; Taha M; Ismail NH; Kashif SM; Rahim F; Jamil W; Hariono M; Yusuf M; Wahab H
    Eur J Med Chem; 2015 Nov; 105():156-70. PubMed ID: 26491979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors.
    Xu XT; Deng XY; Chen J; Liang QM; Zhang K; Li DL; Wu PP; Zheng X; Zhou RP; Jiang ZY; Ma AJ; Chen WH; Wang SH
    Eur J Med Chem; 2020 Mar; 189():112013. PubMed ID: 31972390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.
    Doddaramappa SD; Lokanatha Rai KM; Srikantamurthy N; Chandra ; Chethan J
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3671-5. PubMed ID: 26152425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Hydroxyl Group on the Interaction of Carboxylated Flavonoid Derivatives with S. Cerevisiae α-Glucosidase.
    Lu H; Qi Y; Zhao Y; Jin N
    Curr Comput Aided Drug Des; 2020; 16(1):31-44. PubMed ID: 30345924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
    Peytam F; Takalloobanafshi G; Saadattalab T; Norouzbahari M; Emamgholipour Z; Moghimi S; Firoozpour L; Bijanzadeh HR; Faramarzi MA; Mojtabavi S; Rashidi-Ranjbar P; Karima S; Pakraad R; Foroumadi A
    Sci Rep; 2021 Jun; 11(1):11911. PubMed ID: 34099819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
    Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
    Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
    Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
    Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
    Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management.
    Ullah S; Mirza S; Salar U; Hussain S; Javaid K; Khan KM; Khalil R; Atia-Tul-Wahab ; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2020; 16(6):826-840. PubMed ID: 31195949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
    Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
    Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA; Babkov DA; Prokhorova TY; Sturova EA; Muleeva DR; Demidov MR; Osipov DV; Osyanin VA; Klimochkin YN
    Chem Biol Drug Des; 2017 Dec; 90(6):1184-1189. PubMed ID: 28585419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
    Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
    Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.